Trial intelligence / Profile preview

Cannabidiol for Severe Behavior Problems in Children With Autism

NCT04517799Phase 2Active, not recruiting

Sponsor
University of California, San Diego
Start
Jun 2020
Primary completion
Aug 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of cannabidiol in Autism Spectrum Disorder (ASD), sponsored by University of California, San Diego. Started Jun 2020; status: active, not recruiting.

02

Drugs

cannabidiol
03

Conditions

Autism Spectrum Disorder (ASD)

Beyond the preview

Go deeper on NCT04517799.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04517799.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call